article thumbnail

Phil and Teva Pharmaceuticals Launch New Program to Improve Access to the Digihaler® Family of Inhalers to Support Asthma Management

Digital Health Global

Via the PhilRx Patient Access Platform, patients can now access Teva Pharmaceuticals’ Digihaler® family of inhalers SAN FRANCISCO–(BUSINESS WIRE)– Phil Inc., The goal of Phil and Teva Pharmaceuticals’ partnership is to help enable patients to receive and refill their Digihaler medication quickly, easily and affordably.

article thumbnail

Why CES 2022 Will Be Keynoted by a Health Care Executive

Health Populi

That a pharmaceutical company executive is speaking on the main stage at CES speaks to the category’s mainstreaming beyond elite athletes and smartwatches that track activity. Beyond tracking activity/steps, exercise and weight via digital means, more patients began to track blood pressure with connected cuffs and wrist-worn devices.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Aptar Signs Enterprise Agreement with Biogen to Operate and Develop Digital Health Solutions

Digital Health Global

Physio.me: a digital exercise companion that offers at-home, tailored exercises to patients with neuromuscular disorders who can measure and share their progress with their care team and can increase their likelihood to achieve their physical goals.

article thumbnail

Why #CES2022 Will Be Keynoted By A Health Care Innovator for the First Time

Health Populi

That a pharmaceutical company executive is speaking on the main stage at CES speaks to digital health’s mainstreaming beyond elite athletes and smartwatches that track activity. Beyond tracking activity/steps, exercise and weight via digital means, more patients began to track blood pressure with connected cuffs and wrist-worn devices.

article thumbnail

Redi Health Lands $14 Million Investment to Continue Improving Patient Health Outcomes by Connecting Pharma, Providers, and Patients in One Platform

Healthcare IT Today

This results in a non-adherence rate of approximately 70%, resulting in an estimated annual revenue loss of $637 billion for the pharmaceutical industry. This is the first pharmaceutical platform that enables the free flow of real-time information with Redi Health’s unique compliance architecture.

article thumbnail

Redi.Health Sees Tremendous Growth for Platform that Empowers Patients to Understand, Manage and Track their Health with Digital Support

Healthcare IT Today

Redi.Health combines health management technology and pharmaceutical manufacturer support into one platform to enable patients to manage their complete health with a single interface. We understand how vital it is for outcomes and look forward to working with the Redi.Health team through its next phase of growth.”.

article thumbnail

Will Consumers Cross the Cost-and-Trust Chasm Between Prescription Drugs and Hospitals?

Health Populi

patients’ negative views of the pharmaceutical industry in this study was the opioid epidemic. Over one-half of Americans blame pharmaceutical companies as most responsible for the opioid crisis, followed by physicians, whom 39% of health consumers blame, and patients, whom 38% of people blame. Exacerbating U.S.